Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 05:22 am
Shanghai RAAS Blood Products Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 3,046.52 million compared to CNY 2,038.07 million a year ago. Revenue was CNY 3,046.52 million compared to CNY 2,038.07 million a year ago. Net income was CNY 1,396.17 million compared to CNY 1,095.59 million a year ago. Basic earnings per share from continuing operations was CNY 0.207 compared to CNY 0.173 a year ago. Diluted earnings per share from continuing operations was CNY 0.207 compared to CNY 0.173 a year ago.